UNSPSC 51373002: Bremazocine

This classification denotes an opioid receptor agonist with the molecular formula C20H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ISF76M2DBE, chemically known as 2,6-methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl- but generally known as bremazocine, which bears US NIH Compound Identifier 1223. European Medicines Agency schedules Bremazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05884MIG.

UNSPSC 51373002 Bremazocine is a Commodity code with minimal recent state and local procurement activity. The single recent solicitation in the data set—Seminole County, Florida's IFB60459723LAS—does not align with the code's nominal scope; the opportunity solicits naloxone and drug deactivation systems for community health initiatives, not bremazocine or related opioid medications. State and local governments do not appear to be actively procuring bremazocine as a standalone pharmaceutical commodity at this time, and the mismatch between the code assignment and the actual goods sought suggests either a data-classification anomaly or dormant buying activity under this particular code.

Without documented recent bremazocine procurement, no issuing-body mix, geographic concentration pattern, or representative opportunities in the code's true scope can be characterized from available records. A business development professional evaluating this code should treat it as inactive in the current state and local procurement environment and monitor for future activity rather than pursue immediate opportunities.